文献速递消化与肝胆胰病理细胞病理与分子病理

肝细胞腺瘤与局灶性结节性增生的混合性病变:两例临床病理及分子研究

Hybrid lesions of hepatocellular adenoma and focal nodular hyperplasia: a clinicopathological and molecular study of two cases
RSS 订阅 · Histopathology · 2026-10-20

本文报道两例罕见的肝细胞腺瘤(HCA)与局灶性结节性增生(FNH)混合性病变,通过组织病理、免疫组化和靶向二代测序分析。例1为HNF1α失活型HCA与FNH等比例混合,例2以HCA为主伴周边FNH小结节。分子结果支持碰撞机制,FNH为独立非肿瘤性病变。

要点

  • HCA与FNH可在同一结节内混合,尤其HNF1α失活型HCA。
  • FABP1表达缺失和谷氨酰胺合成酶地图样表达可区分两种成分。
  • 分子特征不共享支持碰撞机制,FNH非起源于HCA。

核心结论

  • HCA尤其HNF1α失活型可罕见与FNH共存,两种成分分子和免疫组化特征不同,支持碰撞机制。

研究设计与样本

  • 两例病例的临床病理、免疫组化和靶向二代测序分析。

主要发现

  • 例1肿瘤6.0 cm,HNF1α失活型HCA与FNH大致等比例紧密混合但组织学分明。
  • 例2肿瘤9.5 cm,以HNF1α失活型HCA为主,周边FNH小结节呈结节套结节。
  • 两例HCA成分FABP1表达缺失,FNH成分保留FABP1并呈谷氨酰胺合成酶地图样表达。
  • 例1 HNF1A和FLT1突变仅见于HCA成分,两成分突变不共享。
  • 例2 HNF1A剪接位点突变见于两成分及非肿瘤胆囊,为胚系起源;HCA成分另有ATM和FAT4体细胞突变。

临床怎么用

  • 诊断混合性HCA-FNH需结合形态学、FABP1和谷氨酰胺合成酶免疫组化。
  • 分子检测有助于区分碰撞病变与单一肿瘤的异质性。

局限性

  • 仅两例病例,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aims Hybrid lesions containing distinct components of hepatocellular adenoma (HCA) and focal nodular hyperplasia (FNH) within a single nodule are exceptionally rare. This study aimed to investigate the biological nature of these unusual lesions. Methods and results The two cases identified to date were examined by histopathological, immunohistochemical and targeted next-generation sequencing analyses. In case 1, the hybrid tumour (6.0 cm) consisted of approximately equal proportions of HNF1α-inactivated HCA and FNH, which were intimately admixed but remained histologically distinct. In case 2, the tumour (9.5 cm) consisted predominantly of HNF1α-inactivated HCA but contained a small peripheral nodule of FNH, resulting in a nodule-in-nodule appearance. The HCA components in both cases showed loss of FABP1 expression, whereas the FNH components retained FABP1 expression and showed a map-like pattern of glutamine synthetase expression. Next-generation sequencing in case 1 demonstrated that the mutations were not shared between the HCA and FNH components, with HNF1A and FLT1 mutations identified only in the HCA component. In case 2, the same HNF1A splice-site mutation was identified in both the HCA and FNH components, but was also present in the non-neoplastic gallbladder, confirming its germline origin. The HCA component, but not the FNH component, additionally harboured somatic mutations in ATM and FAT4. Conclusion HCA, particularly the HNF1α-inactivated subtype, rarely coexists with FNH. The distinct molecular and immunohistochemical profiles of the two components support a collision mechanism, indicating that the FNH component represents a separate non-neoplastic lesion and arguing against one component arising from the other.

来源:Histopathology,查看原文。版权归原作者所有。

引用

  1. Histopathology:Hybrid lesions of hepatocellular adenoma and focal nodular hyperplasia: a clinicopathological and molecular study of two cases

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。